SVP Global Clinical Development
Dr Brown joined Telix in 2020 and leads Telix’s product portfolio in her role as the Global Senior Vice President of Product Portfolio Management. Over the last 25 years, Tracey has founded and acted as the Chief Scientific Officer or Chief Development Officer in several global biotechnology companies (Meditech, Alchemia and Anatara Lifesciences) and worked with European and USA biotechnology companies to co-develop several oncology products, taking products from conception through to registration. Through this process, Tracey has developed broad-ranging experience in the manufacture of chemical and biological therapeutics, development and implementation of preclinical and clinical development plans, regulatory affairs via interaction with international regulatory agencies and management of clinical trials (Phase I-III). Tracey obtained her PhD in Biochemistry and Molecular Biology from Monash University, is a Graduate of the Australian Institute of Company Directors and holds an adjunct Associate Professorship at Monash University.